CI&T Reports Third Quarter Financial Results
CI&T (NYSE: CINT) reported impressive 3Q21 results, registering net revenue of R$376.0 million, a 55% year-over-year increase. The growth was driven by higher demand and the Dextra acquisition, contributing 19% to the revenue. Pro forma net revenue stood at R$411.1 million. Despite a net loss of R$2.2 million, adjusted net profit was R$24.5 million. The company expects 4Q21 revenue of at least R$440.0 million, indicating a 66% year-over-year growth. CI&T maintains a strong demand outlook for digital transformation services and expects full-year revenue growth of 38% in 2021.
- 55% year-over-year net revenue growth in 3Q21.
- Pro forma net revenue of R$411.1 million.
- 66% revenue growth expected for 4Q21.
- Expansion of client base with 75 clients generating over R$1 million in net revenue.
- Net loss of R$2.2 million in 3Q21.
- Significant increase in SG&A expenses (80%) due to new hires and IPO preparations.
- Impairment of intangible assets of R$21.8 million impacting financials.
Our financial results from 3Q21 and 9M21 contemplate the consolidation of Dextra as of
3Q21 Highlights:
-
Net revenue of
R , a$376.0 million 55% growth year-over-year (57% in constant currency basis). -
44% net revenue growth in the U.S. market compared with 3Q20. -
Pro forma net revenue of
R .$411.1 million
We are very excited to present a robust
On
The number of clients with net revenue above
We onboarded 1,364 net new employees during 3Q21, including 1,167 from Dextra, totaling 5,398 CI&Ters by the end of the quarter. We continue to develop our people training actions (
During the quarter, we began a new R&D joint project, named
Pro forma financial highlights, including the Dextra acquisition as if the acquisition had occurred on
For 3Q21(1):
-
Pro forma net revenue of
R .$411.1 million -
Pro forma adjusted EBITDA of
R and$91.8 million 22.3% adjusted EBITDA margin. -
Pro forma net profit of
R .$1.7 million -
Pro forma adjusted net profit of
R and$27.4 million 6.7% adjusted net profit margin.
For 9M21:
-
Pro forma net revenue of
R .$1,160.5 million -
Pro forma adjusted EBITDA of
R and$277.5 million 23.9% adjusted EBITDA margin. -
Pro forma net profit of
R and$88.8 million 7.6% net profit margin. -
Pro forma adjusted net profit of
R and$117.2 million 10.1% adjusted net profit margin.
(1) The Pro Forma numbers for the three months ended
3Q21 CI&T Financial highlights, including the Dextra acquisition as of
-
Net revenue of
R , an increase of$376.0 million R compared to 3Q20, a$133.1 million 55% growth in the period, of which36% was organic growth and19% was related to the Dextra acquisition as ofAugust 10th . -
Net revenue growth on a constant currency basis was
57% year-over-year. -
3Q21 net revenue breakdown:
-
by industry vertical: financial services
36% ; food & beverages21% ; pharmaceuticals and cosmetics14% ; technology, media and telecom12% ; and others17% . -
by geographic region:
USA 44% ;Brazil 51% ;Asia Pacific andJapan 3% ; andEurope 2% . -
by client concentration: top one client
17% ; and top 10 clients60% .
-
by industry vertical: financial services
-
Adjusted EBITDA of
R , an increase of$80.1 million R or$14.8 million 23% over 3Q20. Adjusted EBITDA margin was21.3% . -
Net loss of
R , compared to a net profit of$2.2 million R in the same quarter of 2020.$39.5 million -
Adjusted net profit of
R in the quarter, a reduction of$24.5 million R in relation to 3Q20. Adjusted net profit margin was$15.3 million 6.5% .
Comments on the 3Q21 financial performance
Net revenue was
The costs of services provided amounted to
As a result, gross profit was
Selling, general and administrative (SG&A) expenses in 3Q21 totaled
Other operating expenses of
Adjusted EBITDA totaled
Net financial expenses were
Therefore, the net loss of
Cash Flow and Other Metrics
-
Cash generated from operating activities was
R in the 9M21, compared to$90.2 million R in the 9M20.$102.7 million -
Cash and cash equivalents totaled
R at the end of 3Q21, while total debt (loans and borrowings) ended the quarter at$113.4 million R .$782.1 million -
Net debt (defined as total debt (loans and borrowings) minus cash and cash equivalents) at the end of the quarter was
R .$668.7 million -
Considering the net proceeds from the IPO of
US , net of underwriting discounts and commissions, the Company has a cash position higher than its outstanding debt as of November, 2021.$156.7 million - Total headcount at the end of 3Q21 was 5,398 CI&Ters, an addition of 1,364 people, including 1,167 from Dextra, when compared to 2Q21.
Business Outlook
We continue to see strong demand for digital transformation services worldwide. We expect our revenue growth to continue accelerating during 4Q21, based on our engagement with current clients and existing master services agreements, combined with our pipeline of potential new clients, as well as the contribution of net revenue from the consolidation of Dextra.
Therefore, we expect our net revenue in the fourth quarter of 2021 to be at least
For the full year of 2021, we expect our pro forma net revenue to be at least
These expectations are forward-looking statements. See "Cautionary Statement on Forward-Looking Statements" below.
Initial Public Offering (IPO)
On
Conference Call Information
About
Basis of accounting and functional currency
Non-IFRS Financial Measures
We regularly monitor certain financial and operating metrics to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions. These non-IFRS financial measures include Adjusted Gross Profit, Adjusted Gross Profit Margin, EBITDA, EBITDA Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Profit for the period, Adjusted Net Profit Margin for the period, Net Revenue at Constant Currency and Net Revenue Increase at Constant Currency, and should be considered in addition to results prepared in accordance with IFRS, but not as substitutes for IFRS results. In addition, our calculation of these non-IFRS financial measures may be different from the calculation used by other companies, and therefore comparability may be limited. These non-IFRS financial measures are provided as additional information to enhance investors’ overall understanding of the historical and current financial performance of our operations. See "Reconciliation of Non-IFRS measures, including Dextra as of
We monitor our net revenue at constant currency and net revenue increase at constant currency. As the impact of foreign currency exchange rates is highly volatile and difficult to predict, we believe Net Revenue at Constant Currency and Net Revenue Increase at Constant Currency allow us to better understand the underlying business trends and performance of our ongoing operations on a period-over-period basis by eliminating the effect of fluctuations in the exchange rates we use in the translation of our Net revenue in foreign currencies into Brazilian reais. We calculate Net Revenue at Constant Currency and Net Revenue Increase at Constant Currency by translating Net revenue from entities reporting in foreign currencies into Brazilian reais using the comparable foreign currency exchange rates from the prior period.
Cautionary Statement on Forward–Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, which include but are not limited to: the statements under "Business outlook," including expectations relating to revenues and other financial or business metrics; statements regarding relationships with clients; and any other statements of expectation or belief. The words “believe,” “will,” “may,” “may have,” “would,” “estimate,” “continues,” “anticipates,” “intends,” “plans,” “expects,” “budget,” "scheduled,” “forecasts” and similar words are intended to identify estimates and forward looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements represent our management's beliefs and assumptions only as of the date of this press release. You should read this press release with the understanding that our actual future results may be materially different from what we expect. These statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from results expressed or implied in this press release. Such risk factors include, but are not limited to, those related to: the current and future impact of the COVID-19 pandemic on our business and industry; the effects of competition on our business; uncertainty regarding the demand for and market utilization of our services; the ability to maintain or acquire new client relationships; general business and economic conditions; our ability to successfully integrate Dextra; and our ability to successfully execute our growth strategy and strategic plans. Additional information concerning these and other risks and uncertainties are contained in the "Risk Factors" section of
Reconciliation of Non-IFRS measures, including Dextra as of
The following table presents a reconciliation of our Non-IFRS measures, such as adjusted gross profit, EBITDA, adjusted EBITDA and adjusted net profit for the following periods:
Three months ended September | Nine months ended |
|||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||
(in thousands of Brazilian reais) | (in thousands of Brazilian reais) | |||||||||||
Net Revenue | 375,970 |
|
242,897 |
|
987,586 |
|
691,152 |
|
||||
Gross Profit | 129,124 |
|
92,582 |
|
346,600 |
|
256,580 |
|
||||
Reconciliation of Adjusted Gross Profit | ||||||||||||
Depreciation and amortization (cost of services provided) | 10,345 |
6,092 |
23,121 |
18,091 |
||||||||
Stock Options | 116 |
43 |
348 |
62 |
||||||||
Adjusted Gross Profit | 139,584 |
|
98,717 |
|
370,069 |
|
274,733 |
|
||||
Adjusted Gross Profit Margin | 37.1 |
% |
40.6 |
% |
37.5 |
% |
39.7 |
% |
||||
Reconciliation of EBITDA | ||||||||||||
Net profit (loss) for the period | (2,208 |
) |
39,538 |
|
82,129 |
|
98,253 |
|
||||
Adjustments | ||||||||||||
Net finance costs | 22,416 |
|
1,891 |
|
26,102 |
|
14,036 |
|
||||
Income tax expense | 18,857 |
|
16,386 |
|
57,515 |
|
46,287 |
|
||||
Depreciation and amortization | 14,083 |
|
7,559 |
|
30,102 |
|
22,452 |
|
||||
EBITDA | 53,147 |
|
65,374 |
|
195,848 |
|
181,028 |
|
||||
EBITDA Margin | 14.1 |
% |
26.9 |
% |
19.8 |
% |
26.2 |
% |
||||
Reconciliation of Adjusted EBITDA | ||||||||||||
Net profit for the period | (2,208 |
) |
39,538 |
|
82,129 |
|
98,253 |
|
||||
Adjustments | ||||||||||||
Net finance costs | 22,416 |
|
1,891 |
|
26,102 |
|
14,036 |
|
||||
Income tax expense | 18,857 |
|
16,386 |
|
57,515 |
|
46,287 |
|
||||
Depreciation and amortization | 14,083 |
|
7,559 |
|
30,102 |
|
22,452 |
|
||||
Stock Options | 193 |
|
213 |
|
693 |
|
733 |
|
||||
Consulting Expenses | 4,895 |
|
320 |
|
5,357 |
|
320 |
|
||||
Government grants | (4 |
) |
(673 |
) |
(1,418 |
) |
(1,318 |
) |
||||
Impairment | 21,818 |
|
- |
|
21,818 |
|
- |
|
||||
Adjusted EBITDA | 80,048 |
|
65,234 |
|
222,298 |
|
180,763 |
|
||||
Adjusted EBITDA Margin | 21.3 |
% |
26.9 |
% |
22.5 |
% |
26.2 |
% |
||||
Reconciliation of Adjusted Net Profit (loss) | ||||||||||||
Net profit (loss) for the period | (2,208 |
) |
39,538 |
|
82,129 |
|
98,253 |
|
||||
Adjustments | ||||||||||||
Impairment | 21,818 |
|
- |
|
21,818 |
|
- |
|
||||
Consulting Expenses | 4,895 |
|
320 |
|
5,357 |
|
320 |
|
||||
Adjusted Net profit (loss) for the period | 24,504 |
|
39,858 |
|
109,304 |
|
98,573 |
|
||||
Adjusted Net profit (loss) Margin for the period | 6.5 |
% |
16.4 |
% |
11.1 |
% |
14.3 |
% |
||||
Net Revenue in Constant Currency | 380,707 |
|
242,832 |
|
- |
|
- |
|
In calculating Adjusted Gross Profit, we exclude cost components that are not related to the direct management of our services. For the periods herein, the adjustments applied were: (i) depreciation and amortization related to costs of services provided; and (ii) stock options compensation plan expenses.
In calculating Adjusted EBITDA, we exclude components that are not related to the direct management of our services. For the periods herein, the adjustments were: (i) consulting expenses related to corporate reorganization and secondary public offering costs, as well as mergers and acquisitions activity; (ii) government grants related to tax reimbursement in the Chinese subsidiary; (iii) stock options compensation plan expenses; and (iv) the impairment related to the discontinuation of certain investments made by Dextra on certain in progress intangible assets related to digital platforms following the closing of the Dextra acquisition.
In calculating Adjusted Net Profit, we exclude cost components that are not related to the direct management of our services. For the periods herein, the adjustments applied were: (i) consulting expenses related to corporate reorganization and secondary public offering costs, as well as mergers and acquisitions activity; and (ii) the impairment related to the discontinuation of certain investments made by Dextra on certain in progress intangible assets related to digital platforms following the closing of the Dextra acquisition.
We calculate Net Revenue at Constant Currency and Net Revenue growth at Constant Currency by translating Net revenue from entities reporting in foreign currencies into Brazilian reais using the comparable foreign currency exchange rates from the prior period.
Reconciliation of Non-IFRS measures Pro Forma, including the Dextra acquisition as if the acquisition had occurred on
(in thousands of Brazilian Reais - R$, unaudited)
Three months ended
|
Nine months ended
|
||||
Pro forma Net Revenue | 411,106 |
|
1,160,545 |
|
|
Pro forma Cost | (267,184 |
) |
(744,193 |
) |
|
Pro forma Gross Profit | 143,922 |
|
416,352 |
|
|
Pro forma Selling, general, and administrative | (70,078 |
) |
(193,364 |
) |
|
Pro forma Impairment loss on trade receivables and contract assets | (1,662 |
) |
(1,938 |
) |
|
Pro forma Other income (expenses) net | (25,228 |
) |
(24,745 |
) |
|
Pro forma Operating profit before financial income | 46,954 |
|
196,305 |
|
|
Pro forma Net finance costs | (28,491 |
) |
(48,691 |
) |
|
Pro forma Profit before Income tax | 18,463 |
|
147,614 |
|
|
Pro forma Income Tax | (16,748 |
) |
(58,840 |
) |
|
Pro forma Net profit (loss) for the period | 1,715 |
|
88,774 |
|
|
Reconciliation of Pro forma EBITDA | |||||
Pro forma Net profit (loss) for the period | 1,715 |
|
88,774 |
|
|
Adjustments | |||||
Net finance costs | 28,491 |
|
48,691 |
|
|
Income tax expense | 16,748 |
|
58,840 |
|
|
Depreciation and amortization | 18,967 |
|
53,527 |
|
|
Pro forma EBITDA | 65,921 |
|
249,832 |
|
|
Pro forma EBITDA Margin | 16.0 |
% |
21.5 |
% |
|
Reconciliation of Adjusted Pro forma EBITDA | |||||
Pro forma Net profit (loss) for the period | 1,715 |
|
88,774 |
|
|
Adjustments | |||||
Net finance costs | 28,491 |
|
48,691 |
|
|
Income tax expense | 16,748 |
|
58,840 |
|
|
Depreciation and amortization | 18,967 |
|
53,527 |
|
|
Stock Options | 193 |
|
693 |
|
|
Consulting Expenses | 3,825 |
|
6,617 |
|
|
Government grants | (4 |
) |
(1,418 |
) |
|
Impairment | 21,818 |
|
21,818 |
|
|
Adjusted Pro forma EBITDA | 91,753 |
|
277,542 |
|
|
Adjusted Pro forma EBITDA Margin | 22.3 |
% |
23.9 |
% |
|
Reconciliation of Adjusted Pro forma Net Income | |||||
Pro forma Net profit (loss) for the period | 1,715 |
|
88,774 |
|
|
Adjustments | |||||
Consulting Expenses | 3,825 |
|
6,617 |
|
|
Impairment | 21,818 |
|
21,818 |
|
|
Adjusted Pro forma Net profit (loss) for the period | 27,358 |
|
117,209 |
|
|
Adjusted Pro forma Net profit (loss) Margin for the period | 6.7 |
% |
10.1 |
% |
Please refer to the previous page for explanations of the reconciliation items for non-IFRS measures.
(1) The Pro Forma numbers for the three months ended
Unaudited Condensed Consolidated Interim Financial Information
Statement of profit and loss, including Dextra as of
(in thousands of Brazilian Reais - R$, unaudited)
Three months ended |
|
Nine months ended |
||||||||||
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||
Net Revenue | 375,970 |
|
242,897 |
|
987,586 |
|
691,152 |
|
||||
Costs of services provided | (246,846 |
) |
(150,315 |
) |
(640,986 |
) |
(434,572 |
) |
||||
Gross Profit | 129,124 |
|
92,582 |
|
346,600 |
|
256,580 |
|
||||
Selling expenses | (24,122 |
) |
(14,769 |
) |
(61,902 |
) |
(39,278 |
) |
||||
General and administrative expenses | (38,966 |
) |
(20,268 |
) |
(93,056 |
) |
(58,300 |
) |
||||
Research and technological innovation expenses | - |
|
(690 |
) |
(4 |
) |
(2,652 |
) |
||||
Impairment loss on trade receivables and contract assets | (1,662 |
) |
361 |
|
(2,030 |
) |
(5 |
) |
||||
Other income (expenses) net | (25,309 |
) |
599 |
|
(23,862 |
) |
2,231 |
|
||||
(90,059 |
) |
(34,767 |
) |
(180,854 |
) |
(98,004 |
) |
|||||
Operating profit before financial income | 39,065 |
|
57,815 |
|
165,746 |
|
158,576 |
|
||||
Finance income | 17,591 |
|
14,045 |
|
43,421 |
|
32,851 |
|
||||
Finance cost | (40,007 |
) |
(15,936 |
) |
(69,523 |
) |
(46,887 |
) |
||||
Net finance costs | (22,416 |
) |
(1,891 |
) |
(26,102 |
) |
(14,036 |
) |
||||
Profit before Income tax | 16,649 |
|
55,924 |
|
139,644 |
|
144,540 |
|
||||
Income tax expense | ||||||||||||
Current | (28,809 |
) |
(14,178 |
) |
(63,367 |
) |
(42,478 |
) |
||||
Deferred | 9,952 |
|
(2,208 |
) |
5,852 |
|
(3,809 |
) |
||||
Net profit (loss) for the year | (2,208 |
) |
39,538 |
|
82,129 |
|
98,253 |
|
||||
Income attributable to: | ||||||||||||
Controlling shareholders | (2,208 |
) |
39,538 |
|
82,129 |
|
98,253 |
|
||||
Non-controlling interests | - |
|
- |
|
- |
|
- |
|
||||
Net profit (loss) for the year | (2,208 |
) |
39,538 |
|
82,129 |
|
98,253 |
|
||||
Earnings per share | ||||||||||||
Earnings per share – basic (in R$) | (1.25 |
) |
22.46 |
|
46.65 |
|
55.81 |
|
||||
Earnings per share – diluted (in R$) | (1.25 |
) |
22.46 |
|
46.65 |
|
55.14 |
|
Unaudited Condensed consolidated statements of financial information as of
(in thousands of Brazilian Reais - R$, unaudited)
Assets |
|
|
||
Cash and cash equivalents | 113,417 |
162,827 |
||
Trade receivables | 318,400 |
196,256 |
||
Contract assets | 147,603 |
50,625 |
||
Recoverable taxes | 7,933 |
1,016 |
||
Tax assets | 2,651 |
2,117 |
||
Derivatives | 2,842 |
8,837 |
||
Other assets | 27,696 |
12,874 |
||
Total current assets | 620,542 |
434,552 |
||
Recoverables taxes | 3,086 |
3,099 |
||
Deferred tax | 25,985 |
15,152 |
||
Judicial deposits | 3,075 |
3,083 |
||
Other assets | 2,303 |
2,494 |
||
34,449 |
23,828 |
|||
Property, plant and equipment | 55,720 |
38,771 |
||
Intangible assets | 745,766 |
18,166 |
||
Right-of-use assets | 75,138 |
69,765 |
||
876,625 |
126,702 |
|||
Total non-current assets | 911,073 |
150,530 |
||
Total assets | 1,531,615 |
585,082 |
Unaudited Condensed consolidated statements of financial information as of
(in thousands of Brazilian Reais - R$, unaudited)
Liabilities and equity | ||||
Suppliers | 25,053 |
15,312 |
||
Loans and borrowings | 138,694 |
75,377 |
||
Lease liabilities | 20,952 |
14,569 |
||
Salaries and welfare charges | 214,063 |
141,794 |
||
Accounts payable for business combination | 97,701 |
- |
||
Derivatives | 3,295 |
5,392 |
||
Tax liabilities | 13,671 |
6,078 |
||
Other taxes payable | 5,874 |
3,279 |
||
Dividends and interest on equity payable | 4,044 |
30,677 |
||
Contract liability | 3,014 |
9,987 |
||
Indemnity | - |
628 |
||
Other liabilities | 14,855 |
7,899 |
||
Total current liabilities | 541,216 |
310,992 |
||
Loans and borrowings | 643,453 |
13,853 |
||
Lease liabilities | 62,012 |
60,659 |
||
Provisions | 507 |
161 |
||
Accounts payable for business combination | 35,872 |
- |
||
Other liabilities | 694 |
957 |
||
Total non-current liabilities | 742,538 |
75,630 |
||
Equity | ||||
Share capital | 59,542 |
68,968 |
||
Capital reserves | 9,007 |
6,764 |
||
Profit reserves | 146,170 |
109,308 |
||
Other comprehensive income | 33,142 |
13,420 |
||
Total equity | 247,861 |
198,460 |
||
Total equity and liabilities | 1,531,615 |
585,082 |
Unaudited Condensed Consolidated statement of cash flows for the nine months ended
(in thousands of Brazilian Reais - R$, unaudited)
Cash flows from operating activities |
|
|
||||
Net profit for the year | 82,129 |
|
98,253 |
|
||
Adjustments for: | ||||||
Depreciation and amortization | 30,102 |
|
22,452 |
|
||
Gain/loss on the sale of property, plant and equipment and intangible assets | 338 |
|
275 |
|
||
Interest, adjusted for inflation and exchange rate changes | 25,998 |
|
9,161 |
|
||
Interest on lease | 4,409 |
|
3,497 |
|
||
Unrealized gains on financial instruments | 3,898 |
|
6,006 |
|
||
Income tax expense | 57,515 |
|
46,287 |
|
||
Provision for (reversal of) impairment losses on trade receivables and contract assets | 2,030 |
|
5 |
|
||
Write-off (impairment) of intangible assets | 21,818 |
|
- |
|
||
Provision for labor risks | 346 |
|
13 |
|
||
Exchange rate changes on indemnity | - |
|
(4,413 |
) |
||
Share-based plan | 694 |
|
733 |
|
||
Remeasurement of Right-of-Use assets | 247 |
|
- |
|
||
Others | (195 |
) |
(119 |
) |
||
Reduction (Increase) in operating assets and liabilities | ||||||
Trade receivables | (87,669 |
) |
(30,283 |
) |
||
Contract assets | (67,530 |
) |
(16,272 |
) |
||
Other taxes recoverable | (13,260 |
) |
(4,548 |
) |
||
Current tax assets | (2 |
) |
505 |
|
||
Judicial deposits | 7 |
|
- |
|
||
Suppliers | 4,075 |
|
2,821 |
|
||
Salaries and welfare charges | 43,788 |
|
38,889 |
|
||
Tax liabilities | (3,797 |
) |
(7,940 |
) |
||
Other taxes payable | 1,448 |
|
2,295 |
|
||
Contract liability | (9,036 |
) |
(15,479 |
) |
||
Payment of share-based indemnity | (628 |
) |
(38,386 |
) |
||
Other receivables and payables, net | (6,538 |
) |
(11,047 |
) |
||
Cash generated from operating activities | 90,187 |
|
102,705 |
|
||
Income tax paid | (44,468 |
) |
(30,128 |
) |
||
Interest paid on loans and borrowings | (2,296 |
) |
(2,243 |
) |
||
Interest paid on lease | (3,972 |
) |
(3,496 |
) |
||
Net cash from operating activities | 39,451 |
|
66,838 |
|
||
Cash flows from investment activities | ||||||
Acquisition of property and equipment and intangible assets | (22,112 |
) |
(16,422 |
) |
||
Business combinations | (650,000 |
) |
- |
|
||
Net cash (used in) investment activities | (672,112 |
) |
(16,422 |
) |
||
Cash flows from financing activities | ||||||
Share-based plan contributions | 989 |
|
1,751 |
|
||
Dividends paid | (71,039 |
) |
(30,977 |
) |
||
Interest on equity, paid | (713 |
) |
(2,679 |
) |
||
Payment of lease liabilities | (12,407 |
) |
(12,070 |
) |
||
Proceeds from loans and borrowings | 740,596 |
|
144,270 |
|
||
Payment of loans and borrowings | (71,702 |
) |
(69,242 |
) |
||
Net cash from (used in) financing activities | 585,724 |
|
31,053 |
|
||
Net increase in cash and cash equivalents | (46,937 |
) |
81,469 |
|
||
Cash and cash equivalents as of |
162,827 |
|
79,500 |
|
||
Exchange variation effect on cash and cash equivalents | (2,937 |
) |
(7,565 |
) |
||
Cash reduction due to spin-off effect | (7,752 |
) |
- |
|
||
Cash increase due to business combination | 8,216 |
|
- |
|
||
Cash and cash equivalents at the end of the period | 113,417 |
|
153,404 |
|
Unaudited Pro Forma Condensed Consolidated Financial Information
Pro forma statement of profit and loss for the nine months ended
(in thousands of Brazilian Reais - R$, unaudited)
Dextra | Transaction Accounting Adjustments |
|||||||||||
Net revenue | 987,586 |
|
172,959 |
|
1,160,545 |
|
||||||
Costs of services provided | (640,986 |
) |
(103,207 |
) |
(744,193 |
) |
||||||
Gross profit | 346,600 |
|
69,752 |
|
- |
|
416,352 |
|
||||
|
||||||||||||
|
||||||||||||
Selling expenses | (61,902 |
) |
(1,021 |
) |
- |
|
(62,923 |
) |
||||
General and administrative expenses | (93,056 |
) |
(20,010 |
) |
(17,370 |
) |
(130,436 |
) |
||||
Research and technological innovation expenses | (4 |
) |
- |
|
- |
|
(4 |
) |
||||
Impairment loss on trade receivables and contract assets | (2,030 |
) |
92 |
|
- |
|
(1,938 |
) |
||||
Other income (expenses) net | (23,862 |
) |
(884 |
) |
- |
|
(24,746 |
) |
||||
Operating profit before financial income | 165,746 |
|
47,929 |
|
(17,370 |
) |
196,305 |
|
||||
|
||||||||||||
Finance income | 43,421 |
|
224 |
|
- |
|
43,645 |
|
||||
Finance cost | (69,523 |
) |
(1,852 |
) |
(20,961 |
) |
(92,336 |
) |
||||
Net finance costs | (26,102 |
) |
(1,628 |
) |
(20,961 |
) |
(48,691 |
) |
||||
|
||||||||||||
Profit before Income tax | 139,644 |
|
46,301 |
|
(38,331 |
) |
147,614 |
|
||||
Income tax | (57,515 |
) |
(14,358 |
) |
13,033 |
|
(58,840 |
) |
||||
Net profit for the period | 82,129 |
|
31,943 |
|
(25,298 |
) |
88,774 |
|
||||
|
||||||||||||
Earnings per share |
|
|||||||||||
Earnings per share – basic (in R$) | 0.047 |
|
0.050 |
|
||||||||
Earnings per share – diluted (in R$) | 0.047 |
|
0.050 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211201006203/en/
Investor Relations Contact:
Eduardo Galvão
egalvao@ciandt.com
Media Relations Contact:
ciandt@illumepr.com
Source:
FAQ
What are CI&T's 3Q21 financial results?
How did the Dextra acquisition affect CI&T's revenue?
What is CI&T's expected revenue for the fourth quarter of 2021?
What was CI&T's net profit in 3Q21?